Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × SCLC × Thoracic × Clear all

Phase

Phase 2 5 Phase 1 3 Phase 3 2 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 67 Lung Neoplasms 38 Neoplasms 9 Small Cell Lung Carcinoma 8 NSCLC 7 Colorectal Neoplasms 5 Brain Neoplasms 5 Prostatic Neoplasms 4 Adenocarcinoma of Lung 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Mesothelioma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Multiple Myeloma 2 Liver Neoplasms 2 Laryngeal Neoplasms 2 Hematologic Neoplasms 2 Glioma 2 Gastrointestinal Neoplasms 2 Erdheim-Chester Disease 2 Carcinoma, Squamous Cell 2 Anorexia 2 Advanced Non-small Cell Lung Cancer 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡